Potential Drug Target and Biomarker for Allergies and Asthma (G2206)

Target Name: MS4A2

NCBI ID: G2206

Potential Drug Target and Biomarker for Allergies and Asthma

MS4A2, also known as immunoglobulin E receptor (IgE receptor), is a protein that plays a crucial role in the immune system. It is a high affinity receptor with a beta-polypeptide that is expressed in various tissues throughout the body. MS4A2 has been identified as a potential drug target and a biomarker for various diseases, including allergies, asthma, and autoimmune disorders.

The human body has an immune system that is responsible for protecting the body against foreign substances, such as bacteria, viruses, and other pathogens. This system is made up of various components, including antibodies, which are proteins that are produced by B cells to recognize and neutralize foreign substances in the body.

One of the proteins that is responsible for recognizing and interacting with foreign substances is the IgE receptor. This receptor is a type of protein that is expressed in various tissues throughout the body, including the skin, eyes, and mucous membranes. It is characterized by a long cytoplasmic tail that is involved in the interaction with other cells and molecules.

MS4A2 is a high affinity receptor that is specifically designed to recognize and interact with IgE. It has a beta-polypeptide that is similar in sequence to the Fc portion of IgE. This means that when a foreign substance binds to MS4A2, it can trigger an immune response that includes the production of antibodies, which can help to neutralize the foreign substance in the body.

MS4A2 has been identified as a potential drug target for various diseases, including allergies, asthma, and autoimmune disorders. Allergies and asthma are conditions that result in the production of antibodies that trigger an immune response. In people with allergies, the immune system attacks the body's own tissues, resulting in symptoms such as itching, swelling, and inflammation. In people with asthma, the immune system attacks the body's airways, resulting in symptoms such as coughing, wheezing, and shortness of breath.

MS4A2 has been shown to be involved in the development and progression of these conditions. Studies have shown that people with allergies or asthma are more likely to have high levels of MS4A2 in their bodies. Additionally, studies have shown that blocking the activity of MS4A2 can help to alleviate symptoms of allergies and asthma.

MS4A2 has also been identified as a potential biomarker for various diseases, including allergies and asthma. The levels of MS4A2 have been shown to be elevated in people with these conditions, and studies have shown that blocking the activity of MS4A2 can help to reduce symptoms.

In conclusion, MS4A2 is a protein that plays a crucial role in the immune system. It is a high affinity receptor that is specifically designed to recognize and interact with IgE. Studies have shown that MS4A2 is involved in the development and progression of allergies and asthma, and it has also been identified as a potential biomarker for these conditions. Therefore, MS4A2 is a potential drug target and a biomarker for various diseases, including allergies and asthma.

Protein Name: Membrane Spanning 4-domains A2

Functions: High affinity receptor that binds to the Fc region of immunoglobulins epsilon. Aggregation of FCER1 by multivalent antigens is required for the full mast cell response, including the release of preformed mediators (such as histamine) by degranulation and de novo production of lipid mediators and cytokines. Also mediates the secretion of important lymphokines. Binding of allergen to receptor-bound IgE leads to cell activation and the release of mediators responsible for the manifestations of allergy

More Common Targets